Welcome to the Mastery of Myeloma registration website!
Join us for one of these educational events and earn up to 4.0 credit hours of continuing education.
All meetings take place from 7:30 am – 1:00 pm and include breakfast and lunch.
There are no fees for participation.
| September 11, 2010 – Washington, DC The Willard InterContinental 1401 Pennsylvania Avenue NW Washington, DC 20004 |
October 16, 2010 – Boston, MA Mandarin Oriental Boston 776 Boylston Street Boston, MA 02199 |
| September 25, 2010 – New York, NY Millenium Hilton 55 Church Street New York, NY 10007 |
October 23, 2010 – San Diego, CA Hotel Solamar 435 6th Avenue San Diego, CA 92101 |
| October 2, 2010 – Chicago, IL Renaissance Blackstone Chicago Hotel 636 South Michigan Avenue Chicago, IL 60605 |
October 30, 2010 – Tampa, FL Renaissance Tampa International Plaza Hotel 4200 Jim Walter Boulevard Tampa, FL 33607 |
| October 9, 2010 – Philadelphia, PA Hotel Palomar Philadelphia 117 South 17th Street Philadelphia, PA 19103 |
November 6, 2010 – Houston, TX Houston Marriott at the Texas Medical Center 6580 Fannin Street Houston, TX 77030 |
Program Overview
This live, interactive continuing education activity is designed to address the "real-world" challenges faced by clinicians who treat multiple myeloma through a multidisciplinary training approach. The faculty team comprises national and regional myeloma thought leaders. Using a grand rounds approach, the multidisciplinary team members, through case examples that mimic day-to-day practice, will address appropriate practices in multiple myeloma management. Participants will have the opportunity to design treatment strategies for each case prior to an in-depth evidence-based analysis by the experts. Participants will have the opportunity to ask patient-related questions in a peer-to-peer style forum.
Learning Objectives
At the conclusion of this educational activity, participants should be able to:
- Select appropriate treatment sequencing approaches for individual multiple myeloma patients based on pre-existing comorbidities
- Design a comprehensive management plan tailored for myeloma-related complications such as renal impairment, bone complications, asthenia, and anemia
- Identify myeloma treatment-associated side effects
- Choose appropriate interventions to manage side effects of myeloma treatments such as gastrointestinal side effects, peripheral neuropathy, and VTE
Target Audience
This activity is designed for physicians, nurse practitioners, nurses, physician assistants, and pharmacists who have an interest in enhancing their clinical skills in the management of multiple myeloma.
Agenda
| 7:30 am – 7:55 am | Breakfast, Registration and Pre-Activity Form |
| 7:55 am – 8:00 am | Welcome and Introduction |
| 8:00 am – 10:30 am | Considerations in Practice Update: Real-World Patient Challenges, Faculty Critical Assessment and Ask the Experts Part I Newly Diagnosed Patient, Renal Impairment and Bone Disease After practice update presentations, three cases will be presented (newly diagnosed patients; renal impairment; and bone disease) and an opportunity provided for clinicians to work together to develop a management strategy. Faculty will provide data for best management approaches and critically discuss the most appropriate management plan. Attendees will have the opportunity to ask questions of the experts related to either the presented cases or to their own patients. |
| 10:30 am – 10:40 am | Break |
| 10:40 am – 1:00 pm | Considerations in Practice Update: Real-World Patient Challenges, Faculty Critical Assessment and Ask the Experts Part II Relapsed/Refractory Patient and Side Effect Management After practice update presentations, three cases will be presented (relapsed/refractory; peripheral neuropathy; VTE, anemia, asthenia, infection and GI side effects) and an opportunity provided for clinicians to work together to develop a management strategy. Faculty will provide data for best management approaches and critically discuss the most appropriate management plan. Attendees will have the opportunity to ask questions of the experts related to either the presented cases or to their own patients. |
| 1:00 pm | Conclusions and Closing Remarks Lunch, Post-activity Questions, Survey Completion and Adjournment |
Accreditation
CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 4.0 contact hours of Continuing Education Credit.
Universal Activity Number: 827-000-09-235-L01-P. Knowledge-based CPE activity.
NURSING CREDIT
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 4.0 contact hours. Program Number: 09-235-227
For information on applicability and acceptance of continuing nursing education credit for this activity, please consult your professional licensing board.
Disclosure
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity.
Planner and Provider Financial Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director; and Gene Tombler, PhD, medical director, have nothing to disclose.
Ralph Boccia, MD, clinical reviewer for this activity, has received honoraria related to speakers’ bureau activities from Celgene and Amgen as well as consultant fees from Amgen.
Conflict of Interest Resolution
To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and fair balanced.
Off-Label/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
All participants must complete the Activity Evaluation Form. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates will be mailed 6 to 8 weeks following receipt of a completed, qualified form.
If you have any questions regarding this activity, please contact MediCom at 800-408-4242, ext. 128 or email info@managingmyeloma.com
Supported by an educational grant from Millennium Pharmaceuticals, Inc.
©2010 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067. 1-800-408-4242
No portion of this material may be copied or duplicated without the expressed permission of MediCom.